News
Under [the plaintiffs'] reading, virtually all pharmaceutical product-support services would qualify as a kickback,” U.S.
Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...
As weight loss jabs like Ozempic become ever more popular, doctors are growing increasingly concerned about their gnarly side ...
Ozempic, which is prescribed for certain adults with type 2 diabetes, can cause side effects. Learn about its potential side effects and how to manage them.
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...
Aluminum-adsorbed vaccines were not associated with the development of chronic diseases in youth, according to a large study ...
1d
MedPage Today on MSNMyeloma Drug's Comeback Nixed by FDA PanelThe comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...
An expert discusses how different adverse event profiles of antibody-drug conjugates (ADCs) influence treatment decisions by requiring careful patient selection based on comorbidities like prior lung ...
An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results